Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Long Chain Fatty Acid Oxidation Disorders”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Not applicableStudy completedNCT00328159
What this trial is testing

Nutritional Therapy of the Deficits of Oxidation Mitochondrial of the Fatty Acids

Who this might be right for
Inborn Errors of Metabolism
Assistance Publique - Hôpitaux de Paris 20
Not applicableEnded earlyNCT04812106
What this trial is testing

Long-Chain Fatty Acid Oxidation Disorders Online Disease Monitoring Program

Who this might be right for
Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
Ultragenyx Pharmaceutical Inc 8
Testing effectiveness (Phase 2)Study completedNCT01494051
What this trial is testing

High Protein Diet in Patients With Long-chain Fatty Acid Oxidation Disorders

Who this might be right for
Very Long-chain Acyl-CoA Dehydrogenase DeficiencyTrifunctional Protein DeficiencyCarnitine Palmitoyltransferase 2 Deficiency+1 more
Oregon Health and Science University 13
Testing effectiveness (Phase 2)Study completedNCT02214160
What this trial is testing

Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies

Who this might be right for
Carnitine Palmitoyltransferase (CPT I or CPT II) DeficiencyVery Long Chain Acyl-CoA Dehydrogenase (VLCAD) DeficiencyLong-chain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) Deficiency+2 more
Ultragenyx Pharmaceutical Inc 94
Not applicableLooking for participantsNCT04602325
What this trial is testing

Systemic Biomarkers of Brain Injury From Hyperammonemia

Who this might be right for
Urea Cycle DisorderOrganic AcidemiaMaple Syrup Urine Disease+3 more
Children's National Research Institute 24
Large-scale testing (Phase 3)Active Not RecruitingNCT05933200
What this trial is testing

Determine the Effect of Triheptanoin Compared With Even-Chain MCT on MCEs in Pediatric Patients With LC-FAOD

Who this might be right for
Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
Ultragenyx Pharmaceutical Inc 69
Not applicableNo Longer AvailableNCT01461304
What this trial is testing

Compassionate Use of Triheptanoin (C7) for Inherited Disorders of Energy Metabolism

Who this might be right for
Very Long-chain acylCoA Dehydrogenase (VLCAD) DeficiencyCarnitine Palmitoyltransferase Deficiencies (CPT1, CPT2)Mitochondrial Trifunctional Protein Deficiency+5 more
Jerry Vockley, MD, PhD
Very early researchStudy completedNCT05411835
What this trial is testing

Oral Ketones and Exercise Among Patients With Long-chain Fatty Acid Oxidation Disorders

Who this might be right for
Long-chain 3-hydroxyacyl-CoA Dehydrogenase DeficiencyCarnitine Palmitoyltransferase Deficiency 2Very Long Chain Acyl Coa Dehydrogenase Deficiency+1 more
Oregon Health and Science University 5
Testing effectiveness (Phase 2)Study completedNCT01886378
What this trial is testing

UX007 (Triheptanoin) in Participants With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)

Who this might be right for
Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)Carnitine Palmitoyltransferase (CPT II) DeficiencyVery Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency+2 more
Ultragenyx Pharmaceutical Inc 29
Not applicableAvailableNCT03773770
What this trial is testing

Expanded Access to Triheptanoin

Who this might be right for
Long Chain Fatty Acid Oxidation Disorders
Ultragenyx Pharmaceutical Inc
Not applicableStudy completedNCT03768817
What this trial is testing

Clinical Outcome of Triheptanoin Treatment in Patients With Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) Treated Under Expanded Access Program

Who this might be right for
Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
Ultragenyx Pharmaceutical Inc 20
Not applicableStudy completedNCT04482049
What this trial is testing

A Prospective Study of the Disease Characteristics of Adult Patients With Long Chain Fatty Acid Oxidation Disorders

Who this might be right for
Fatty Acid Oxidation Disorder
Reneo Pharma Ltd 61
Testing effectiveness (Phase 2)Study completedNCT01379625
What this trial is testing

Study of Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorder

Who this might be right for
Very Long-chain acylCoA Dehydrogenase (VLCAD) DeficiencyCarnitine Palmitoyltransferase 2 (CPT2) DeficiencyMitochondrial Trifunctional Protein (TFP) Deficiency+1 more
Oregon Health and Science University 32
Not applicableActive Not RecruitingNCT04632953
What this trial is testing

Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program

Who this might be right for
Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
Ultragenyx Pharmaceutical Inc 150
Not applicableStudy completedNCT04400422
What this trial is testing

Experience of Using Lipano in Children With Fatty Acid Oxidation Disorders

Who this might be right for
Fatty Acid Oxidation Disorder
Dr. Schär AG / SPA 5
Not applicableLooking for participantsNCT05924555
What this trial is testing

Exercise Intolerance Study in Long Chain Fatty Acid Oxidation Disorders

Who this might be right for
Long-chain Fatty Acid Oxidation Disorders
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 50